Quantum Genomics SA (ALQGC) - Cash Flow Conversion Efficiency

Latest as of June 2023: -4.706x

Based on the latest financial reports, Quantum Genomics SA (ALQGC) has a cash flow conversion efficiency ratio of -4.706x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-7.64 Million ≈ $-8.93 Million USD) by net assets (€1.62 Million ≈ $1.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Quantum Genomics SA fund operations to measure how many days the company can operate on defensive assets alone.

Quantum Genomics SA - Cash Flow Conversion Efficiency Trend (2012–2022)

This chart illustrates how Quantum Genomics SA's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Quantum Genomics SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Quantum Genomics SA ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
CaliberCos Inc. Class A Common Stock NASDAQ:CWD	-0.173x
Bumi Citra Permai Tbk JK:BCIP	-0.032x
Indo Oil Perkasa PT JK:OILS	-0.085x
Albion Resources Ltd AU:ALB	-0.617x
SIV Capital Ltd AU:SIV	0.020x
Thunderstruck Resources Ltd V:AWE	-0.004x
Axiom Properties Ltd AU:AXI	-0.145x
Tartana Minerals Ltd AU:TAT	-0.217x

Annual Cash Flow Conversion Efficiency for Quantum Genomics SA (2012–2022)

The table below shows the annual cash flow conversion efficiency of Quantum Genomics SA from 2012 to 2022. For the full company profile with market capitalisation and key ratios, see how much is Quantum Genomics SA worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2022-12-31	€3.61 Million ≈ $4.22 Million	€-20.21 Million ≈ $-23.63 Million	-5.603x	-218.28%
2021-12-31	€9.67 Million ≈ $11.30 Million	€-17.02 Million ≈ $-19.89 Million	-1.760x	-261.87%
2020-12-31	€24.65 Million ≈ $28.82 Million	€-11.99 Million ≈ $-14.02 Million	-0.486x	+56.12%
2019-12-31	€9.41 Million ≈ $11.00 Million	€-10.43 Million ≈ $-12.19 Million	-1.109x	-20.70%
2018-12-31	€11.87 Million ≈ $13.87 Million	€-10.90 Million ≈ $-12.74 Million	-0.919x	-2.15%
2017-12-31	€8.87 Million ≈ $10.37 Million	€-7.98 Million ≈ $-9.33 Million	-0.899x	-91.70%
2016-12-31	€11.79 Million ≈ $13.79 Million	€-5.53 Million ≈ $-6.47 Million	-0.469x	-19.75%
2015-12-31	€8.02 Million ≈ $9.38 Million	€-3.14 Million ≈ $-3.67 Million	-0.392x	-101.82%
2014-12-31	€-129.79K ≈ $-151.74K	€-2.79 Million ≈ $-3.26 Million	21.503x	+3447.81%
2013-12-31	€-1.63 Million ≈ $-1.90 Million	€-987.00K ≈ $-1.15 Million	0.606x	-9.37%
2012-12-31	€-918.08K ≈ $-1.07 Million	€-614.00K ≈ $-717.83K	0.669x	--

About Quantum Genomics SA

PA:ALQGC France Biotechnology

Market Cap

$5.87 Million

€5.02 Million EUR

Market Cap Rank

#28558 Global

#515 in France

Share Price

€0.07

Change (1 day)

+0.00%

52-Week Range

€0.07 - €0.07

All Time High

€9.73